Arbutus Medical
Seed Round in 2023
Founded in 2014, Arbutus Medical develops and manufactures surgical power tools aimed at reducing healthcare costs. Its flagship product is a radically affordable orthopedic power tool system used in trauma centers, veterinary hospitals, military deployments, and hospitals worldwide.
Avivo Biomedical
Grant in 2022
Avivo Biomedical operates as a preclinical-stage company, has identified enzymes that convert the cell surface antigens that determine a person’s blood group to group O, the universal donor type.
LightIntegra Technology
Venture Round in 2020
LightIntegra Technology Inc., established in 2009 and headquartered in Vancouver, Canada, is a privately-funded medical diagnostics company specializing in innovative in-vitro diagnostic tests. The company's flagship product, ThromboLUX, is designed to provide healthcare professionals with qualitative and quantitative information about microparticle content in platelet samples. LightIntegra offers the ThromboLUX test kit, control kit, and ThromboSight, a software tool for analyzing test results. Founded by Dr. Elisabeth Maurer, a research scientist from Canadian Blood Services R&D labs, the company aims to minimize platelet refractoriness through its products.
Sonic Incytes Medical Corp
Seed Round in 2020
Sonic Incytes Medical Corp develops handheld ultrasound solutions for point-of-care assessment and monitoring of chronic liver diseases. It uses quantitative ultrasound and elastography with artificial intelligence to provide deeper measurements, larger tissue samples, and single-probe operation without recalibrations, enabling guidance for diagnostics and procedures. The devices assess liver stiffness, attenuation, and fat fraction to support diagnosis and management of liver health. The company was incorporated in 2012 and is based in Vancouver, Canada.
BarrelWise Technologies
Seed Round in 2020
BarrelWise Technologies specializes in developing advanced technical systems for the wine industry. Its flagship product, the FS1 System, enables wineries to perform routine free SO2 checks on-site, reducing analysis time from days to minutes while maintaining lab-level accuracy.
Acuva Technologies
Series B in 2019
Founded in 2014, Acuva Technologies specializes in developing and providing advanced water treatment solutions. The company's core technology is based on ultraviolet light emitting diodes (UV-LED), designed to purify drinking water by effectively eliminating viruses, bacteria, and other biological contaminants.
ALAViDA
Venture Round in 2019
Alavida Health Ltd., based in Vancouver, Canada, specializes in digital health rehabilitation for alcohol and substance use addiction. The company's core offering is a digital platform that delivers evidence-based treatment programs, combining cognitive-behavioral therapy, motivational interviewing, and targeted pharmacotherapy, all guided by professional therapists.
Starling Minds
Seed Round in 2019
Founded in 2013, Starling Minds offers digital mental health solutions, including cognitive behavioral therapy programs. It caters to businesses, healthcare providers, and educational institutions, aiming to enhance emotional resilience, manage stress, anxiety, and depression, thereby improving workplace productivity.
LightIntegra Technology
Series A in 2019
LightIntegra Technology Inc., established in 2009 and headquartered in Vancouver, Canada, is a privately-funded medical diagnostics company specializing in innovative in-vitro diagnostic tests. The company's flagship product, ThromboLUX, is designed to provide healthcare professionals with qualitative and quantitative information about microparticle content in platelet samples. LightIntegra offers the ThromboLUX test kit, control kit, and ThromboSight, a software tool for analyzing test results. Founded by Dr. Elisabeth Maurer, a research scientist from Canadian Blood Services R&D labs, the company aims to minimize platelet refractoriness through its products.
Aspect Biosystems
Venture Round in 2018
Aspect Biosystems Ltd. is a biotechnology company based in Vancouver, Canada, specializing in 3D bioprinting and tissue engineering. Founded in 2013, the company leverages proprietary microfluidic 3D bioprinting technology to develop bioprinted tissue therapeutics aimed at transforming disease treatment. By integrating therapeutic cells and materials science, Aspect Biosystems creates allogeneic cell-based tissue therapeutics that can replace or repair damaged organ functions. The company also provides a Lab-on-a-printer technology that allows precise control over biomaterial composition and structure during tissue fabrication. Its innovative platform supports the development of novel therapeutics and enhances understanding in fundamental biology and disease research, catering to pharmaceutical firms and academic institutions focused on respiratory diseases and regenerative medicine. Aspect Biosystems is actively collaborating with researchers and industry leaders to address significant challenges in the field of regenerative medicine.
Microbiome Insights
Venture Round in 2017
Microbiome Insights Inc., based in Vancouver, Canada, is a leading provider of microbiome analysis and testing services aimed at academic and industrial researchers. Founded in 2015, the company specializes in the analysis of microbial communities, including bacteria, viruses, and fungi that inhabit various environments, such as humans, animals, and plants. Microbiome Insights offers a comprehensive suite of services that includes quantifying microbial populations, analyzing the genetic potential and gene expression of microbial communities, and optimizing study design and workflow. Their multidisciplinary team comprises experts in ecology, microbiology, infectious diseases, and genetics, ensuring a high level of expertise and fast, reliable results tailored to meet the needs of clients across numerous research applications in human health, agriculture, and environmental science.
CuePath Innovation
Seed Round in 2017
CuePath Innovation is a health tech company that designs medication packaging for seniors and provides a medication monitoring platform and mobile service that enable families and caregivers to remotely track elderly patients' medication intake. The platform connects seniors with care professionals and healthcare organizations through smart disposable medication packaging, creating a care circle to help ensure adherence and reduce caregiving stress. Founded in 2015 and based in Vancouver, Canada.
Anandia
Venture Round in 2016
Anandia Labs is a biotechnology company dedicated to the cannabis industry, focusing on providing advanced analytical testing services. The company offers comprehensive testing for potency, pesticides, microbes, and terpenes, catering to licensed producers and patients. Utilizing its specialized scientific knowledge, Anandia Labs assists clients in interpreting testing results and addressing any identified non-conformities. Additionally, Anandia develops a cannabis biotechnology platform that incorporates cannabinoid pathway patents and modern plant breeding techniques, ensuring that consumers receive safe and effective cannabis products. Through its commitment to science and quality, Anandia Labs aims to enhance the overall safety and efficacy of the cannabis industry.
Verdi is a developer of advanced data science platforms focused on enhancing precision agriculture, particularly in irrigation management. The company creates scalable control systems that facilitate plant-level healthcare and automation, even in challenging farming environments. By leveraging geospatial analytics, Verdi's network of irrigation valves allows farmers and growers to make informed irrigation decisions. This innovative approach enables users to customize water and fertilizer application at the individual plant level, thereby optimizing cultivation processes. Verdi aims to empower agricultural professionals with the tools needed to effectively build, manage, and scale their farming operations.
Verdi Expeditions is a scalable platform for agricultural automation and tailored plant health.